Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5G23D | — |
Kinrix was administered instead of Pedirix to a four-month-old patient; Underage administration of Kinrix instead of Pediarix; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 4-month-old female patient who received DTPa-IPV (Kinrix) (batch number 5G23D, expiry date 21-AUG-2026) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. Concomitant products included Pediarix. On 05-SEP-2025, the patient received Kinrix. The patient did not receive Pediarix. On 05-SEP-2025, an unknown time after receiving Kinrix, the patient experienced wrong vaccine administered (Verbatim: Kinrix was administered instead of Pedirix to a four-month-old patient) and inappropriate age at vaccine administration (Verbatim: Underage administration of Kinrix instead of Pediarix). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.
PEDIARIX